History of IDH
With over 40 years of industry experience and strategic expansion, IDH has built a strong market position across products and geographies, with a scalable platform that is set for further strong growth.
Establishment of MK Lab
Dr. Moamena Kamel, Professor of Immunology at Cairo University, founds the MK Lab which later merges with Al Mokhtabar in 2004
Al Borg was founded
Founded by a group of four doctors, Al Borg is the first medical laboratory in Egypt to have an efficient hub, spoke and spike model
IDH established by Abraaj
Abraaj acquires 76.8% of Al Borg to establish IDH Caymans
Branches(a) : 127
Expansion of IDH
Acquisition of 99.9% stake in Molecular Diagnostics Centre
Branches(a) : 154
Expansion of product offering
Acquisition of 54.98% stake in Medical Genetics Centre
Increase of stake in Al Borg to 80% post its delisting
Branches(a) : 195
Building infrastructure and scale
Penetration in Sudan and Jordan comes with acquisition of Ultralab and Biolab, respectively
Branches(a) : 210
Creating a leading platform
Acquisition of 99.9% of Al Mokhtabar (Al Borg’s biggest competitor)
Increase of stake in Al Borg to 99.3%
Branches(a) : 214
Integration and further expansion
Establishes the largest automated lab in Egypt
Diversifies into adjacent medical services
Branches(b) : 262 (2013); 288 (2014)
Successful completion of IPO on the LSE
Standard listing on the London Stock Exchange (LSE)
50% offering at USD 4.45 per share
Market capitalization of USD 667.5 mn
Completes investment in Nigeria
Establishes Dynasty Group Holdings, a JV between IDH and Man Capital, to invest in Eagle Eye Echo-Scan Services Limited, a leading medical diagnostics business based in Nigeria.
LAUNCHES AL BORG SCAN
Expands into the high-value, adjacent radiology segment through the launch of Al Borg Scan.
Branches (b): 414
Launches new subsidiary “Wayak” to offer data-driven healthcare support
Wayak will leverage the Group’s patient database to capture new growth opportunities in the healthcare management space and offer targeted services to its customers.
Branches (b): 452
Adapts to continue growing
Despite the unprecedented difficulties related to Covid-19, IDH’s swift service adjustments to changing market
dynamics allowed for yet another year of solid top- and bottom-line growth.
Branches (b): 481
A record-breaking year
IDH completed its dual-listing on EGX; delivered record-breaking top- and bottom-line results; transformed service offering and delivery capabilities setting the foundations for long-term growth.
Branches (b): 502
A new chapter
Despite significant macroeconomic difficulties in its home market, IDH maintained the growth of its conventional business while signing an agreement to expand its footprint to a fifth market, Saudi Arabia.
Branches (b): 552
Fostering Sustainable Growth
Despite continued economic pressures in three of IDH’s markets, the Company posted impressive top-line growth, even including Covid contributions in 2022.
Branches (b): 601
Broadening our reach
IDH officially launches Saudi Arabian operations adding a new market to its portfolio. In August, the Company successfully concludes its delisting process from the Egyptian Exchange (EGX) maintaining its standard listing on the London Stock Exchange (LSE).
Note:
(a) Branches refer to core operations of Al Borg and Al Mokhtabar in Egypt
(b) Branches refer to the IDH group
Source: Company data